SAT-292-Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST

P Eddowes; M Allison; E Tsochatzis; Q Anstee; D Sheridan; IN Guha; J Cobbold; V Paradis; PBP Newsome

doi:10.1016/s0618-8278(19)31524-5

SAT-292-Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST

P Eddowes, M Allison, E Tsochatzis, Q Anstee, D Sheridan, IN Guha, J Cobbold, V Paradis, PBP Newsome

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1016/s0618-8278(19)31524-5
Publication status	Published - Apr 2019

Access to Document

10.1016/s0618-8278(19)31524-5

Cite this

Eddowes, P., Allison, M., Tsochatzis, E., Anstee, Q., Sheridan, D., Guha, IN., Cobbold, J., Paradis, V., & Newsome, PBP. (2019). SAT-292-Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST. https://doi.org/10.1016/s0618-8278(19)31524-5

@conference{09de7ea1cf434ea4892f9a4d86f0c3c8,

title = "SAT-292-Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST",

author = "P Eddowes and M Allison and E Tsochatzis and Q Anstee and D Sheridan and IN Guha and J Cobbold and V Paradis and PBP Newsome",

year = "2019",

month = apr,

doi = "10.1016/s0618-8278(19)31524-5",

language = "English",

}

Eddowes, P, Allison, M, Tsochatzis, E, Anstee, Q, Sheridan, D, Guha, IN, Cobbold, J, Paradis, V & Newsome, PBP 2019, 'SAT-292-Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST'. https://doi.org/10.1016/s0618-8278(19)31524-5

TY - CONF

T1 - SAT-292-Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST

AU - Eddowes, P

AU - Allison, M

AU - Tsochatzis, E

AU - Anstee, Q

AU - Sheridan, D

AU - Guha, IN

AU - Cobbold, J

AU - Paradis, V

AU - Newsome, PBP

PY - 2019/4

Y1 - 2019/4

U2 - 10.1016/s0618-8278(19)31524-5

DO - 10.1016/s0618-8278(19)31524-5

M3 - Conference paper (not formally published)

ER -